ScholarIQanswers from OpenAlex
Steno Diabetes Center Copenhagen
FunderResearch funding and supported work
Steno Diabetes Center Copenhagen is a funder indexed in ScholarIQ from OpenAlex.
How many works does Steno Diabetes Center Copenhagen have?
ScholarIQindexed works
Steno Diabetes Center Copenhagen has 2,334 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Steno Diabetes Center Copenhagen?
ScholarIQopenalex
The OpenAlex for Steno Diabetes Center Copenhagen is on the source record.
What are the most-cited papers on Steno Diabetes Center Copenhagen?
ScholarIQmost cited works
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
Vlado Perkovic, Katherine R. Tuttle, Peter Rossing, Kenneth W. Mahaffey, Johannes F.E. Mann, George L. Bakris, Florian M.M. Baeres, Thomas Idorn, Heidrun Bosch‐Traberg, Nanna L. Lausvig, Richard Pratley
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial
Gerasimos Filippatos, Stefan D. Anker, Rajiv Agarwal, Luis M. Ruilope, Peter Rossing, George L. Bakris, Christoph Tasto, Amer Joseph, Peter Kolkhof, Andrea Lage, Bertram Pitt, on behalf of the FIGARO-DKD Investigators
Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials
Johannes F.E. Mann, Thomas K. Hansen, Thomas Idorn, Lawrence A. Leiter, Steven P. Marso, Peter Rossing, Jochen Seufert, Sayeh Tadayon, Tina Vilsbøll
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes
Muthiah Vaduganathan, Gerasimos Filippatos, Brian Claggett, Akshay S. Desai, Pardeep S. Jhund, Alasdair D Henderson, Meike Brinker, Peter Kolkhof, Patrick Schloemer, James Lay‐Flurrie, Prabhakar Viswanathan, Carolyn S.P. Lam, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Peter Rossing, Luís M. Ruilope, Stefan D. Anker, Bertram Pitt, Rajiv Agarwal, John J.V. McMurray, Scott D. Solomon
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chronic Kidney Disease in the FLOW Trial
Richard E. Pratley, Katherine R. Tuttle, Peter Rossing, Søren Rasmussen, Vlado Perkovic, Olav Wendelboe Nielsen, Johannes F.E. Mann, Richard J. MacIsaac, Mikhail Kosiborod, Zdravko Kamenov, Thomas Idorn, Marco Bo Hansen, Samy Hadjadj, George L. Bakris, Florian M.M. Baeres, Kenneth W. Mahaffey